MGO One Seven’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Buy |
+14,059
| New | +$236K | 0.01% | 1047 |
|
|
2025
Q1 | – | Sell |
-48,813
| Closed | -$1.08M | – | 1174 |
|
|
2024
Q4 | $1.08M | Buy |
48,813
+33,377
| +216% | +$736K | 0.04% | 413 |
|
|
2024
Q3 | $278K | Buy |
15,436
+478
| +3% | +$8.61K | 0.01% | 790 |
|
|
2024
Q2 | $243K | Buy |
14,958
+3,018
| +25% | +$49K | 0.01% | 844 |
|
|
2024
Q1 | $168K | Buy |
+11,940
| New | +$168K | 0.01% | 860 |
|
|
2023
Q4 | – | Sell |
-13,326
| Closed | -$136K | – | 933 |
|
|
2023
Q3 | $136K | Buy |
13,326
+22
| +0.2% | +$224 | 0.01% | 776 |
|
|
2023
Q2 | $100K | Buy |
13,304
+39
| +0.3% | +$294 | 0.01% | 758 |
|
|
2023
Q1 | $117K | Sell |
13,265
-243
| -2% | -$2.15K | 0.01% | 824 |
|
|
2022
Q4 | $123K | Sell |
13,508
-584
| -4% | -$5.33K | 0.01% | 696 |
|
|
2022
Q3 | $113 | Buy |
14,092
+85
| +0.6% | +$1 | ﹤0.01% | 676 |
|
|
2022
Q2 | $105K | Sell |
14,007
-201
| -1% | -$1.51K | 0.01% | 606 |
|
|
2022
Q1 | $133K | Buy |
+14,208
| New | +$133K | 0.01% | 639 |
|
|
2019
Q1 | – | Sell |
-1,388
| Closed | -$21K | – | 1512 |
|
|
2018
Q4 | $21K | Buy |
+1,388
| New | +$21K | 0.01% | 909 |
|
|
2018
Q1 | $9K | Sell |
555
-24
| -4% | -$389 | ﹤0.01% | 1138 |
|
|
2017
Q4 | $11K | Buy |
+579
| New | +$11K | 0.01% | 1069 |
|